In their novel work, they found that TNF interferes with the tissue-repair program by inducing a soluble natural IL-22 antagonist (IL-22Ra2; IL-22BP) in the colon and abolishes IL-22/STAT3-mediated mucosal repair during colitis. The gene discussed is IL22; the disease is colitis.